Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|May 21, 2014
CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicityM Roustit, X Fonrose, D Montani, et al.
Microvascular Research|July 4, 2014
Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosisF Gaillard-Bigot, M Roustit, S Blaise, et al.
La Revue De Medecine Interne|May 26, 2004
[Isoprostanes: a putative key role in vascular diseases]J-L Cracowski
Clinical Pharmacology and Therapeutics|January 25, 2014
Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept studyM Roustit, F Gaillard-Bigot, S Blaise, et al.
Pathologie-Biologie|July 12, 2005
[Isoprostanes, biomarkers of lipid peroxidation in humans. Part 1. Nomenclature and synthesis]T Durand, J-L Cracowski, O Berdeaux
La Revue De Medecine Interne|August 6, 1999
[Endothelin-1 and cardiovascular diseases]J L Cracowski, F Stanke, G Bessard
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 30, 1999
[Systemic manifestations and development of GPIIbIIIa antibodies in the course of staphylococcal endocarditis. Report of a case]N Lamblin, J L Cracowski, O Leroy
Pageof 9